Jubilant Pharma Limited has recently announced that it has successfully completed safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India using a novel oral drug formulation of Remdesivir in comparison to the commercially available injectable formulation of Remdesivir.
The company has sought authorization for additional studies for this novel oral formulation from the Drug Controller General of India (DCGI).
Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…